as-101
Small moleculeexperimental
Clinical trial activity
10 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00002013)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ammonium trichloro(dioxoethylene-o,o'-)tellurate
- as101
- as101
- as101
- as 101
- as-101
- as-101
- as-101
- trichloro(dioxoethylene-o,o'-)tellurate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01010373 | Phase 2 | Jan 1, 2015 | BioMAS Ltd |
| NCT01555112 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2012 | BioMAS Ltd, Technion University |
| NCT00926354 | Phase 2 | Aug 1, 2009 | BioMAS Ltd, Tel Aviv University |
| NCT00927212 | Phase 2 | Jun 1, 2009 | BioMAS Ltd, Tel Aviv University |
| NCT00788424 | Phase 2 | Nov 1, 2008 | BioMAS Ltd, Hebrew University |
| NCT00418249 | Phase 2 | Jan 2, 2007 | Tel Aviv University |
| NCT00001006 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00002266 | N/A | Nov 2, 1999 | Pfizer |
| NCT00002033 | N/A | Nov 2, 1999 | Pfizer |
| NCT00002013 | N/A | Nov 2, 1999 | Pfizer |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioMAS Ltd | For profit | 5 | 5 | 1 | 2008 |
| Pfizer | For profit | 3 | 3 | 1 | 1999 |
| Tel Aviv University | Academic/Hospital | 3 | 1 | 1 | 2007 |
| Hebrew University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 1999 |
| Technion University | Academic/Hospital | 1 | 0 | 1 | 2012 |
6 organizations
Page 1 / 1